The injections are used for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone.
Domestic liquidity is unlikely to dry up any time soon and that could limit market downside, says Harsha Upadhyaya, CIO Equity at Kotak Mutual Fund.